Identifying high-risk melanoma patients is crucial for effective follow-up and treatment planning. The DecisionDx-Melanoma test helps dermatologists and oncologists pinpoint patients at greater risk of recurrence or metastasis, enabling personalized surveillance and care plans. By using DecisionDx-Melanoma, clinicians can offer more targeted monitoring strategies, improving outcomes and providing patients with the proactive, individualized care they need. Discover how DecisionDx-Melanoma is advancing melanoma management for better patient care.
